Cargando…

Use of the Dyskinesia Impairment Scale in non‐ambulatory dyskinetic cerebral palsy

AIM: To assess the responsiveness, concurrent validity, and feasibility of the Dyskinesia Impairment Scale (DIS) in non‐ambulatory patients with dyskinetic cerebral palsy (CP). METHOD: The study is a secondary analysis of data collected in the IDYS trial, a randomized controlled trial on the effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Haberfehlner, Helga, Bonouvrié, Laura A, Boeschoten, Karin, Fleuren, Sabine, Monbaliu, Elegast, Becher, Jules G, Vermeulen, R Jeroen, Buizer, Annemieke I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079134/
https://www.ncbi.nlm.nih.gov/pubmed/31784988
http://dx.doi.org/10.1111/dmcn.14415
_version_ 1783507767996186624
author Haberfehlner, Helga
Bonouvrié, Laura A
Boeschoten, Karin
Fleuren, Sabine
Monbaliu, Elegast
Becher, Jules G
Vermeulen, R Jeroen
Buizer, Annemieke I
author_facet Haberfehlner, Helga
Bonouvrié, Laura A
Boeschoten, Karin
Fleuren, Sabine
Monbaliu, Elegast
Becher, Jules G
Vermeulen, R Jeroen
Buizer, Annemieke I
author_sort Haberfehlner, Helga
collection PubMed
description AIM: To assess the responsiveness, concurrent validity, and feasibility of the Dyskinesia Impairment Scale (DIS) in non‐ambulatory patients with dyskinetic cerebral palsy (CP). METHOD: The study is a secondary analysis of data collected in the IDYS trial, a randomized controlled trial on the effects of intrathecal baclofen (ITB). The DIS and Barry–Albright Dystonia Scale (BADS) were conducted at baseline and after 3 months of ITB or placebo treatment. Responsiveness was assessed by comparing the effect sizes and correlation of change after treatment between the DIS and BADS. Concurrent validity was evaluated by assessing the correlations between scales. Feasibility was evaluated for each DIS item by the number of participants who successfully accomplished the item. RESULTS: Thirty‐three non‐ambulatory patients (9 females, 24 males) with dyskinetic CP (ITB‐treated: n=17, mean [SD] age: 14y 1mo [4y 1mo]; placebo‐treated: n=16, mean [SD] age: 14y 7mo [4y]) were included in the study. The effect sizes for BADS and DIS were similar in The ITB‐treated group (−0.29 and −0.22 respectively). Changes after treatment on the DIS dystonia subscale correlated with changes on the BADS (r=0.64; p<0.001). The DIS dystonia subscale and BADS correlated at baseline and follow‐up (r=0.78; p<0.001 and r=0.79; p<0.001). Not all DIS activity items could be performed in this sample of patients. INTERPRETATION: For non‐ambulatory patients with dyskinetic CP, the responsiveness of the DIS equalled the responsiveness of BADS. Concurrent validity was adequate. Feasibility for activity items was restricted in patients with severe dyskinetic CP. WHAT THIS PAPER ADDS: The Dyskinesia Impairment Scale (DIS) and Barry–Albright Dystonia Scale showed similar responsiveness in non‐ambulatory patients with dyskinetic cerebral palsy (CP). No floor or ceiling effect was observed for DIS in non‐ambulatory participants. The concurrent validity of DIS was adequate in non‐ambulatory participants. Patients with dyskinetic CP in Gross Motor Function Classification System levels IV and V could not perform all DIS activity items.
format Online
Article
Text
id pubmed-7079134
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70791342020-03-19 Use of the Dyskinesia Impairment Scale in non‐ambulatory dyskinetic cerebral palsy Haberfehlner, Helga Bonouvrié, Laura A Boeschoten, Karin Fleuren, Sabine Monbaliu, Elegast Becher, Jules G Vermeulen, R Jeroen Buizer, Annemieke I Dev Med Child Neurol Original Articles AIM: To assess the responsiveness, concurrent validity, and feasibility of the Dyskinesia Impairment Scale (DIS) in non‐ambulatory patients with dyskinetic cerebral palsy (CP). METHOD: The study is a secondary analysis of data collected in the IDYS trial, a randomized controlled trial on the effects of intrathecal baclofen (ITB). The DIS and Barry–Albright Dystonia Scale (BADS) were conducted at baseline and after 3 months of ITB or placebo treatment. Responsiveness was assessed by comparing the effect sizes and correlation of change after treatment between the DIS and BADS. Concurrent validity was evaluated by assessing the correlations between scales. Feasibility was evaluated for each DIS item by the number of participants who successfully accomplished the item. RESULTS: Thirty‐three non‐ambulatory patients (9 females, 24 males) with dyskinetic CP (ITB‐treated: n=17, mean [SD] age: 14y 1mo [4y 1mo]; placebo‐treated: n=16, mean [SD] age: 14y 7mo [4y]) were included in the study. The effect sizes for BADS and DIS were similar in The ITB‐treated group (−0.29 and −0.22 respectively). Changes after treatment on the DIS dystonia subscale correlated with changes on the BADS (r=0.64; p<0.001). The DIS dystonia subscale and BADS correlated at baseline and follow‐up (r=0.78; p<0.001 and r=0.79; p<0.001). Not all DIS activity items could be performed in this sample of patients. INTERPRETATION: For non‐ambulatory patients with dyskinetic CP, the responsiveness of the DIS equalled the responsiveness of BADS. Concurrent validity was adequate. Feasibility for activity items was restricted in patients with severe dyskinetic CP. WHAT THIS PAPER ADDS: The Dyskinesia Impairment Scale (DIS) and Barry–Albright Dystonia Scale showed similar responsiveness in non‐ambulatory patients with dyskinetic cerebral palsy (CP). No floor or ceiling effect was observed for DIS in non‐ambulatory participants. The concurrent validity of DIS was adequate in non‐ambulatory participants. Patients with dyskinetic CP in Gross Motor Function Classification System levels IV and V could not perform all DIS activity items. John Wiley and Sons Inc. 2019-11-29 2020-04 /pmc/articles/PMC7079134/ /pubmed/31784988 http://dx.doi.org/10.1111/dmcn.14415 Text en © 2019 The Authors. Developmental Medicine & Child Neurology published by John Wiley & Sons Ltd on behalf of Mac Keith Press This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Haberfehlner, Helga
Bonouvrié, Laura A
Boeschoten, Karin
Fleuren, Sabine
Monbaliu, Elegast
Becher, Jules G
Vermeulen, R Jeroen
Buizer, Annemieke I
Use of the Dyskinesia Impairment Scale in non‐ambulatory dyskinetic cerebral palsy
title Use of the Dyskinesia Impairment Scale in non‐ambulatory dyskinetic cerebral palsy
title_full Use of the Dyskinesia Impairment Scale in non‐ambulatory dyskinetic cerebral palsy
title_fullStr Use of the Dyskinesia Impairment Scale in non‐ambulatory dyskinetic cerebral palsy
title_full_unstemmed Use of the Dyskinesia Impairment Scale in non‐ambulatory dyskinetic cerebral palsy
title_short Use of the Dyskinesia Impairment Scale in non‐ambulatory dyskinetic cerebral palsy
title_sort use of the dyskinesia impairment scale in non‐ambulatory dyskinetic cerebral palsy
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079134/
https://www.ncbi.nlm.nih.gov/pubmed/31784988
http://dx.doi.org/10.1111/dmcn.14415
work_keys_str_mv AT haberfehlnerhelga useofthedyskinesiaimpairmentscaleinnonambulatorydyskineticcerebralpalsy
AT bonouvrielauraa useofthedyskinesiaimpairmentscaleinnonambulatorydyskineticcerebralpalsy
AT boeschotenkarin useofthedyskinesiaimpairmentscaleinnonambulatorydyskineticcerebralpalsy
AT fleurensabine useofthedyskinesiaimpairmentscaleinnonambulatorydyskineticcerebralpalsy
AT monbaliuelegast useofthedyskinesiaimpairmentscaleinnonambulatorydyskineticcerebralpalsy
AT becherjulesg useofthedyskinesiaimpairmentscaleinnonambulatorydyskineticcerebralpalsy
AT vermeulenrjeroen useofthedyskinesiaimpairmentscaleinnonambulatorydyskineticcerebralpalsy
AT buizerannemiekei useofthedyskinesiaimpairmentscaleinnonambulatorydyskineticcerebralpalsy